Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1631 1633 1643 1651 1798
This examiner grants 51% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18980456 | Targeted CRISPR Delivery Platforms | Non-Final OA | University of Massachusetts |
| 18612111 | Targeted CRISPR Delivery Platforms | Non-Final OA | University of Massachusetts |
| 18049724 | COMPLEXES FOR GENE DELETION AND EDITING | Final Rejection | UNIVERSITY OF MASSACHUSETTS |
| 18554139 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 18448499 | KIT FOR PRODUCING ADENO-ASSOCIATED VIRUS, AND USE THEREOF | Non-Final OA | FUJIFILM Corporation |
| 18282645 | METHODS AND MATERIALS FOR TREATING PROPIONIC ACIDEMIA | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17933023 | METHODS FOR MODIFICATION OF TARGET NUCLEIC ACIDS | Final Rejection | BASF PLANT SCIENCE COMPANY GMBH |
| 17933005 | METHODS FOR MODIFICATION OF TARGET NUCLEIC ACIDS | Final Rejection | BASF Plant Science Company GmbH |
| 17102291 | Intrathecal Delivery of Recombinant Adeno-Associated Virus 9 | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 18163253 | Methods and Compositions to Target and Treat Macrophages | Non-Final OA | Massachusetts Institute of Technology |
| 17865375 | Programmable Modification of DNA | Final Rejection | Massachusetts Institute of Technology |
| 17831745 | DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR GENOME EDITING | Final Rejection | Massachusetts Institute of Technology |
| 18547348 | VIRAL VECTOR-BASED GENE THERAPY FOR OCULAR CONDITIONS | Non-Final OA | The Regents of the University of Colorado, A Body Corporate |
| 18902038 | POLYMER NANOPARTICLE COMPOSITIONS FOR NON-VIRAL GENE DELIVERY | Final Rejection | BATTELLE MEMORIAL INSTITUTE |
| 18123413 | METHOD AND SYSTEM FOR DESIGNING POLYNUCLEOTIDE SEQUENCES AND POLYNUCLEOTIDE SEQUENCES OBTAINED THEREBY | Non-Final OA | Ramot at Tel-Aviv University Ltd. |
| 16959878 | TRANSGENIC EUKARYOTIC ORGANISMS AND METHODS FOR GENDER SELECTION | Final Rejection | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy